Israeli, Canadian Companies Team Up to Improve Rare-Disease Diagnosis
Israeli firm Geneyx Genomex and Canadian EpiSign Inc. are collaborating to enhance rare disease diagnosis by combining genetic and gene expression analysis.
Wednesday, 7 October 2026
The Shahar Project, a volunteer initiative, is helping bereaved Israeli families recover hundreds of millions of shekels left by fallen...
Read More →Nineteen teams from 31 Israeli and international firms qualified for NIS 65 billion Tel Aviv metro project tenders, with construction...
Read More →Israel's Supreme Court ruled financial institutions taking over failed housing projects can be liable for buyer compensation for delivery delays.
Read More →Tel Aviv landowners must pay NIS 45 million in betterment levies after the Supreme Court rejected their appeal concerning development...
Read More →British Airways will resume direct flights between Tel Aviv and London on October 25, restoring service after an eight-month suspension...
Read More →Two senior Israeli Transport Ministry officials are under criminal investigation for suspected conflicts of interest and unauthorized outside employment related.
Read More →Israeli mother Mali Yahalomi and daughter Liel, previously missing in Europe, have been apprehended in Namibia for allegedly using forged...
Read More →Police Commissioner and command staff visit southern combat zones, honoring fallen heroes and their bravery in saving lives.
Read More →A federal judge has temporarily blocked the U.S. Department of Education from revealing foreign donor and contractor identities for universities,...
Read More →Israeli firm Geneyx Genomex and Canadian EpiSign Inc. are collaborating to enhance rare disease diagnosis by combining genetic and gene expression analysis.